HD Medical has entered into a distribution agreement with BPL Limited for the distribution of the company’s first pipeline product, ViScope 100. The distribution agreement is valued at USD$10 Million (Rs.45 Crores).

Disclosing this to media persons here today, Mr. Jay Jethwa, Managing Director and CEO of HD Medical Groupsaid, “ViScope is an Audio-Visual Cardiac Screening device that enables doctors to Visulaize the heart sounds along with hearing them better. ViScope also enables the better detection of murmurs and other heart sound components so as to achieve a very effective screening of cardiac anomalies"

Commenting on the agreement, Mr. A. Vijay Simha, Chief Operating Officer and Vice President of BPL Limited said, “The ViScope 100 represents the new paradigm in diagnosis of health for the masses, empowering physicians to diagnose with a greater degree of accuracy and efficiency. It is a true example of how advanced technology can potentially bring down the prevailing high costs of health care and make healthcare affordable to the millions”.

Mr Jethwa added that HD Medical Group is a global company with offices in India, USA and Australia. Most of its research and development for the technology is carried out in Chennai. The company was founded in 2005 to commercialise its proprietary and patented heart sound technology. The company has 14 patents pending and one patent that has already been granted in the field of cardiac auscultation.

Mr Jethwa further added that the company is in the process of signing similar distribution agreements in other parts of the world. Mr. Damon Coffman, the global Chief Technology Officer of the company, said that the company would be introducing more advanced diagnostic products in Europe, US and Japan in the near future.

“The company has decided to undertake all its research and development in India as the human talent pool is very good here for all its R&D requirements. The company has strategic collaboration with many leading global institutions for clinical trials and technology validation”, said Mr. Arvind Thiagarajan, the chief inventor.

Mr B Ramakrishnan, CEO, Corporate Clinic, Chennai and the financial advisor of HD Medical Group said that the company had already raised in excess of USD$ 8 Million towards development of the product.

- End -

HD Medical Group is a global company with offices in India, USA and Australia. Most of its research and development for the technology is carried out in Chennai. The company was founded in 2005 to commercialise its proprietary and patented heart sound technology. The company has 14 patents pending and one patent that has already been granted in the field of cardiac auscultation.